73 related articles for article (PubMed ID: 34879787)
21. Impact of facility type and volume in locally advanced esophageal cancer.
Muslim Z; Stroever S; Poulikidis K; Connery CP; Nitzkorski JR; Bhora FY
Asian Cardiovasc Thorac Ann; 2024 Jan; 32(1):19-26. PubMed ID: 37994000
[TBL] [Abstract][Full Text] [Related]
22. Academic Affiliation and Surgical Volume Predict Survival in Head and Neck Cancer Patients Receiving Surgery.
Farquhar DR; Masood MM; Lenze NR; Sheth S; Patel SN; Lumley C; Zanation AM; Weissler MC; Olshan AF; Hackman TG
Laryngoscope; 2021 Feb; 131(2):E479-E488. PubMed ID: 32449832
[TBL] [Abstract][Full Text] [Related]
23. Impact of Nab-Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer.
Dadi N; Stanley M; Shahda S; O'Neil BH; Sehdev A
Anticancer Res; 2017 Oct; 37(10):5533-5539. PubMed ID: 28982867
[TBL] [Abstract][Full Text] [Related]
24. The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who received definitive surgery of the pancreatic tumor: a retrospective analysis of the National Cancer Database.
Amin S; Baine M; Meza J; Alam M; Lin C
Radiat Oncol; 2020 Jun; 15(1):139. PubMed ID: 32493354
[TBL] [Abstract][Full Text] [Related]
25. Comparison of overall survival in gallbladder carcinoma at academic versus community cancer centers: An analysis of the National Cancer Data Base.
Liu C; Rein L; Clarke C; Mogal H; Tsai S; Christians KK; Gamblin TC
J Surg Oncol; 2020 Aug; 122(2):176-182. PubMed ID: 32383268
[TBL] [Abstract][Full Text] [Related]
26. The Impact of Hospital Neoadjuvant Therapy Utilization on Survival Outcomes for Pancreatic Cancer.
Fisher AV; Abbott DE; Venkatesh M; Leverson GE; Campbell-Flohr SA; Ronnekleiv-Kelly SM; Greenberg CC; Winslow ER; Weber SM
Ann Surg Oncol; 2018 Sep; 25(9):2661-2668. PubMed ID: 30003452
[TBL] [Abstract][Full Text] [Related]
27. Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer.
Chen YW; Mahal BA; Muralidhar V; Nezolosky M; Beard CJ; Den RB; Feng FY; Hoffman KE; Martin NE; Orio PF; Nguyen PL
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):683-90. PubMed ID: 26972640
[TBL] [Abstract][Full Text] [Related]
28. Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers.
David JM; Kim S; Placencio-Hickok VR; Torosian A; Hendifar A; Tuli R
Adv Radiat Oncol; 2019; 4(2):302-313. PubMed ID: 31011675
[TBL] [Abstract][Full Text] [Related]
29. Are Case Volume and Facility Complexity Level Associated With Postoperative Complications After Hip Fracture Surgery in the Veterans Affairs Healthcare System?
Wong JK; Kim TE; Mudumbai SC; Memtsoudis SG; Giori NJ; Howard SK; Oka RK; King R; Mariano ER
Clin Orthop Relat Res; 2019 Jan; 477(1):177-190. PubMed ID: 30179946
[TBL] [Abstract][Full Text] [Related]
30. Association between hospital volume and receipt of treatment and survival in patients with glioblastoma.
Koshy M; Sher DJ; Spiotto M; Husain Z; Engelhard H; Slavin K; Nicholas MK; Weichselbaum RR; Rusthoven C
J Neurooncol; 2017 Dec; 135(3):529-534. PubMed ID: 28836140
[TBL] [Abstract][Full Text] [Related]
31. Hospital facility characteristics and socioeconomic factors on outcomes and treatment in patients with multiple myeloma: National Cancer Database analysis.
Doucette K; Taylor AO; Chan B; Ma X; Ahn J; Vesole DH; Lai C
Ann Hematol; 2023 Jun; 102(6):1443-1458. PubMed ID: 37093241
[TBL] [Abstract][Full Text] [Related]
32. The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysis.
Amin S; Baine M; Meza J; Lin C
BMC Cancer; 2020 Jun; 20(1):538. PubMed ID: 32517661
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcome of patients with advanced pancreatic cancer treated with sequential chemotherapies before the era of modern combination therapy protocols.
Abendroth A; Noureddine R; Abramczyk M; Paul A; Gerken G; Schmid KW; Markus P; Schumacher B; Wiesweg M; Köhler J; Markus M; Mende B; Dechêne A; Schuler M; Kasper S
J Cancer Res Clin Oncol; 2019 Feb; 145(2):445-455. PubMed ID: 30430229
[TBL] [Abstract][Full Text] [Related]
34. Influence of facility volume on long-term survival of patients undergoing esophagectomy for esophageal cancer.
Patel DC; Jeffrey Yang CF; He H; Liou DZ; Backhus LM; Lui NS; Shrager JB; Berry MF
J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1536-1546.e3. PubMed ID: 34247867
[TBL] [Abstract][Full Text] [Related]
35. Facility Volume and Survival in Nasopharyngeal Carcinoma.
Yoshida EJ; Luu M; David JM; Kim S; Mita A; Scher K; Shiao SL; Tighiouart M; Lee NY; Ho AS; Zumsteg ZS
Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):408-417. PubMed ID: 29100787
[TBL] [Abstract][Full Text] [Related]
36. Type and case volume of health care facility influences survival and surgery selection in cases with early-stage non-small cell lung cancer.
Wang S; Lai S; von Itzstein MS; Yang L; Yang DM; Zhan X; Xiao G; Halm EA; Gerber DE; Xie Y
Cancer; 2019 Dec; 125(23):4252-4259. PubMed ID: 31503336
[TBL] [Abstract][Full Text] [Related]
37. Association Between Treatment Facility Volume, Therapy Types, and Overall Survival in Patients With Stage IIIA Non-Small Cell Lung Cancer.
Kommalapati A; Tella SH; Appiah AK; Smith L; Ganti AK
J Natl Compr Canc Netw; 2019 Mar; 17(3):229-236. PubMed ID: 30865920
[TBL] [Abstract][Full Text] [Related]
38. Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010.
Cai S; Hong TS; Goldberg SI; Fernandez-del Castillo C; Thayer SP; Ferrone CR; Ryan DP; Blaszkowsky LS; Kwak EL; Willett CG; Lillemoe KD; Warshaw AL; Wo JY
Cancer; 2013 Dec; 119(23):4196-204. PubMed ID: 24006012
[TBL] [Abstract][Full Text] [Related]
39. The Academic Facility Type Is Associated With Improved Overall Survival for Early-Stage Lung Cancer.
Merritt RE; Abdel-Rasoul M; Fitzgerald M; D'Souza DM; Kneuertz PJ
Ann Thorac Surg; 2021 Jan; 111(1):261-268. PubMed ID: 32615092
[TBL] [Abstract][Full Text] [Related]
40. The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy era.
Chen YW; Ornstein MC; Wood LS; Allman KD; Martin A; Beach J; Gilligan T; Garcia JA; Rini BI
Urol Oncol; 2018 Oct; 36(10):470.e19-470.e29. PubMed ID: 30131292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
